Strongbridge Biopharma plc (SBBP) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 94 transactions totaling $8.8M, demonstrating a bullish sentiment with $8.8M in net insider flow. The most recent transaction on Oct 5, 2021 involved a transaction of 8,060,682 shares valued at $0.
No significant insider buying has been recorded for SBBP in the recent period.
No significant insider selling has been recorded for SBBP in the recent period.
Based on recent SEC filings, insider sentiment for SBBP is bullish with an Insider Alignment Score of 100/100 and a net flow of $8.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Strongbridge Biopharma plc (SBBP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading SBBP stock, having executed 94 transactions in the past 90 days. The most active insider is Bruce Kovner (Executive), who has made 15 transactions totaling $8.4M.
Get notified when executives and directors at SBBP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 5, 2021 | Kovner Bruce | Executive | Other | 8,060,682 | $N/A | $0 | |
| Oct 5, 2021 | J. Long Stephen | Executive | Disposition | 117,793 | $N/A | $0 | |
| Oct 5, 2021 | N. Gill David | Executive | Disposition | 78,058 | $N/A | $0 | |
| Oct 5, 2021 | Kong Garheng | Executive | Disposition | 63,993 | $N/A | $0 | |
| Oct 5, 2021 | W. Sherman Jeffrey | Executive | Disposition | 64,258 | $N/A | $0 | |
| Oct 5, 2021 | Steen Marten | Executive | Disposition | 64,151 | $N/A | $0 | |
| Oct 5, 2021 | H. Steineger Hilde | Executive | Disposition | 64,258 | $N/A | $0 | |
| Oct 5, 2021 | Johnson John | Executive | Disposition | 610,092 | $N/A | $0 | |
| Oct 5, 2021 | J. Cohen Fredric | Executive | Disposition | 160,408 | $N/A | $0 | |
| Oct 5, 2021 | S. Kollender Richard | Executive | Disposition | 234,229 | $N/A | $0 | |
| Oct 5, 2021 | L. Wilhoit Scott | Executive | Disposition | 109,510 | $N/A | $0 | |
| Oct 1, 2021 | N. Gill David | Executive | Payment | 17,763 | $2.06 | $36.6K | |
| Oct 1, 2021 | Kong Garheng | Executive | Payment | 17,763 | $2.06 | $36.6K | |
| Oct 1, 2021 | W. Sherman Jeffrey | Executive | Payment | 17,763 | $2.06 | $36.6K | |
| Oct 1, 2021 | H. Steineger Hilde | Executive | Payment | 17,763 | $2.06 | $36.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 17 | $8.8M | 78.0% |
Payment(F) | 35 | $2.5M | 22.0% |
Other(J) | 1 | $0 | 0.0% |
Disposition(D) | 10 | $0 | 0.0% |
Award(A) | 31 | $0 | 0.0% |
Insiders at Strongbridge Biopharma plc are accumulating shares at an accelerated pace. With 16 insiders making 94 transactions totaling $8.8M in purchases versus $0 in sales, the net buying activity of $8.8M signals strong executive confidence. Bruce Kovner (Executive) leads the buying activity with $8.4M in transactions across all time.